Colorectal Cancer

Cytokine gene therapy shows antitumor effect on small rectal cancers

Published in Cancer Weekly, November 19th, 2002

by Sonia Nichols, senior medical writer - Cytokine gene therapy may be an effective adjuvant for conventional therapies designed for treating colorectal cancers.

In addition, it may be able to prevent the establishment of new tumors from cancer cells seeded during colorectal surgery, according to animal studies performed in Taiwan.

Medical researchers at National Taiwan University Hospital recently issued a report that concluded granulocyte-macrophage colony-stimulating factor (GM-CSF) gene therapy prevents and reduces rectal cancers in murine cancer models.

All untreated mice that were implanted with CT-26 murine cancer cells...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry